A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anaemia by 20 per cent in people mostly aged 70 and over. The results have prompted researchers to suggest that regular monitoring for anaemia be considered for older adults who take low-dose aspirin, and if older adults have concerns about their health or medications they should discuss them with their GP.